• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Advanced BioHealing Inc.

Shire ditches Dermagraft for leg ulcers, just three months after dropping $750M on Advanced BioHealing

August 25, 2011 By MassDevice staff

Shire
Dermagraft

Shire plc (NSDQ:SHPGY) became the latest firm to abandon its pursuit of a leg ulcer indication for the Dermagraft artificial skin patch, after a clinical trial failed to pan out.

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Advanced BioHealing Inc., Clinical Trials, Shire Plc., Smith & Nephew

Cynosure picks up aesthetic laser business for $24.5 million | Acquisitions roundup

June 28, 2011 By MassDevice staff Leave a Comment

Cynosure

Cynosure Inc. (NSDQ:CYNO) announced the $24.5 million acquisition of the assets of Japan-based HOYA ConBio’s aesthetic laser business today.

The Westford, Mass.-based cosmetic laser device maker adds HOYA’s proprietary PhotoAcoustic energy technology to its product portfolio, which also includes the SmoothShapes cellulite reduction system.

The PhotoAcoustic technology uses high-speed energy waves to penetrate skin in nanoseconds, minimizing the amount of heat in each procedure.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Acacia Research Corp., Advanced BioHealing Inc., Cynosure Inc., EraGen Biosciences, HOYA ConBio, Laboratory Corp. of America Holdings, Laser/Light-based Devices, Luminex Corp., Orchid Cellmark Inc., Shire Plc.

ADA diabetes roundup: Mayo Clinic answers the call for progress toward an artificial pancreas

June 27, 2011 By MassDevice staff Leave a Comment

ADA

Plenty more news streamed out of the conference of the American Diabetes Assn. over the weekend, including progress toward an artificial pancreas, data on young diabetics at risk for heart disease and mobile apps for prevention and management of diabetes.

More than 13,500 people gathered in San Diego at the 71st annual scientific conference of the ADA to lead the fight against diabetes, a disease that affects more than 26 million children and adults in the U.S., according to the ADA.

Filed Under: News Well, Research & Development Tagged With: Advanced BioHealing Inc., Mayo Clinic, Shire Plc.

Medtronic’s hospital GPO gamble

May 19, 2011 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Medtronic Inc.’s (NYSE:MDT) decision to cut ties with group purchasing organizations could cost them in sales.

Fridley, Minn.-based Medtronic is watching rival players step in to fill the vacated contracts, including St. Jude Medical Inc. (NYSE:STJ) and Biotronik Inc., each of which announced Novation deals for heart-rhythm devices in April.

Filed Under: Business/Financial News, Healthcare Reform, News Well Tagged With: Advanced BioHealing Inc., Biotronik, Shire Plc.

Quintiles aims to restructure debt with $2 billion in credit | Funding roundup

May 13, 2011 By MedCity News

Funding

Quintiles is resuming its plans to raise more than $2 billion in bank financing.

The Durham, N.C.-based, contract research organization is planning to enter into a new $2.2 billion credit facility, with proceeds from the borrowed funding being used to refinance $1.7 billion in existing debt, including an offer to buy $525 million of 9.5 percent outstanding senior notes that are due in 2014.

Filed Under: News Well Tagged With: Advanced BioHealing Inc., Angiotech, Avedro Inc., CardioDx Inc., Cardiva Medical Inc., DaVita Inc., Lantheus Medical Imaging, Life Technologies Corp., MindChild Medical Inc., MoMelan Technologies, Quintiles, Seventh Sense Biosystems Inc., Sorin Group, Varian Medical Systems, Venture Capital/Private Equity, WaveMark Inc., WaveTec Vision

Organogenesis, Advanced Biohealing stand to benefit from CMS proposal

July 6, 2010 By MassDevice staff Leave a Comment

Advanced BioHealing, Organogenesis logos

Organogenesis Inc. and Advanced BioHealing Inc. may win a new reimbursement code for their skin regenerating systems.

The Centers for Medicare and Medicaid Services proposed temporary, updated coding for artificial skin products in treating diabetic foot ulcers, slated to take effect in 2011.

The proposal would standardize the reimbursement codes for the Apligraf product made by Canton, Mass.-based Organogenesis and Advanced BioHealing’s Dermagraft, which now are reimbursed according to different schemes.

Filed Under: Biotech, Business/Financial News, Contract Manufacturing, News Well Tagged With: Advanced BioHealing Inc., Tissue Regeneration

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy